Posttransfusion red blood cell (RBC) survival determined using biotin-labeled RBCs has distinct advantages over labeling with 51Cr

Transfusion

Volumn 52, Issue 7, 2012, Pages 1596-1598

  Mock, Donald M ^a   Widness, John A ^b   Strauss, Ronald G ^b   Franco, Robert S ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CHROMIUM 51; HEMOGLOBIN A1C;

BIOTINYLATION; CELL LABELING; DIABETES MELLITUS; ERYTHROCYTE LIFESPAN; EX VIVO STUDY; FLOW CYTOMETRY; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; LETTER; LONG TERM CARE;

ANIMALS; BLOOD SUBSTITUTES; ERYTHROCYTES; HUMANS; HYPERSENSITIVITY; MALE; MODELS, THEORETICAL;

EID: 84863807066     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03588.x     Document Type: Letter

References (6)

1. Oliver C, Blake D, Henry S,. Modeling transfusion reactions and predicting in vivo cell survival with kodecytes. Transfusion 2011; 51: 1723-30.
2. Mock DM, Matthews NI, Zhu S, Strauss RG, Schmidt RL, Nalbant D, Cress GA, Widness JA,. Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities. Transfusion 2011; 51: 1047-57.
3. Franco RS,. The measurement and importance of red cell survival. Am J Hematol 2009; 84: 109-14.
4. Franco RS, Yasin Z, Palascak MB, Ciraolo P, Joiner CH, Rucknagel DL,. The effect of fetal hemoglobin on the survival characteristics of sickle cells. Blood 2006; 108: 1073-6.
5. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, Palascak MB, Joiner CH,. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008; 112: 4284-91.
6. Cordle DG, Strauss RG, Lankford G, Mock DM,. Antibodies provoked by the transfusion of biotin-labeled red cells. Transfusion 1999; 39: 1065-9.